Should I reapply if I am told ‘no’?

Yes. Sometimes we say no to companies because they are too early in their journey to extract full value from the MedTech Actuator™ program. Often these companies are good candidates for our early-stage pitch competition, the MedTech Actuator™ Origin. The MedTech Actuator™ Origin will provide you with access to industry mentors and the opportunity to refine your technology and business model. It is free to enter and provides 5 winners with a small cash prize to further develop their startup. If you’ve continued to develop your company and technology — either within the MedTech Actuator™ Origin or on your own — you should consider reapplying for the MedTech Actuator™.

How do you choose which companies to accept into the MedTech Actuator™?

We focus on team, market, technology, and traction.

  • Team: We look for passionate, well rounded founder teams with strong skills in key areas such as technology, clinical, business and commercialisation that have a unique insight into their market and are high-integrity and inspiring leaders with a focus on execution.
  • Market: We like markets within the MedTech, HealthTech and BioTech sectors that are either large but ripe for disruption or underserved or so radically new they don’t yet exist.
  • Technology: Our specialty is deep tech with a regulated path to market. We look for technologies and products with the potential to create an unfair market advantage and a clear path towards strong, protectable IP.
  • Traction: Ideas matter but execution makes the difference. That is why we like to see evidence of early traction or data points validating your core assumptions such as an early proof of concept and safety data, a robust need validation, or expressions of interest from lead users or customers.

What is the application process?

A summary of the information you’ll need to submit can be found here apply. If your application is shortlisted, our expert panel will begin due diligence on your company, and you’ll hear from us to set up a video interview. The most promising teams will be selected to present to our Investment Advisory Board. Based on the decision of this board, you’ll be offered a place in the MedTech Actuator™.

Am I eligible?

Our program is targeted at MedTech, HealthTech and BioTech startups at TRL 4 and above. Our specialty is deep tech with robust IP and a regulated path to market. Slick apps and user interfaces are great, but what gets us excited are radical new technologies like bionics, diagnostics, implants, instrumentation, robotics, personal preventative medicine, telemedicine, AI and VR that will create a step-change in our healthcare systems and economies.

If you are unsure about eligibility or have any other questions about our program, you can submit an expression of interest contact to speak to a Program Manager before submitting an application.